Article
Changing Paradigms in the Treatment of Severe Asthma: The Role of Biologic Therapies.
The journal of allergy and clinical immunology. In practice - 1 Jan 2000
Katial Rohit K, Bensch Greg W, Busse William W, Chipps Bradley E, Denson Joshua L, Gerber Anthony N, Jacobs Joshua S, Kraft Monica, Martin Richard J, Nair Parameswaran, Wechsler Michael E
Abstract excerpt
Cytokine antagonists are monoclonal antibodies that offer new treatment options for refractory asthma but will also increase complexity because they are effective only for patients with certain asthma subtypes that remain to be more clearly defined. The clinical and inflammatory heterogeneity within refractory asthma makes it difficult to manage the disease and to determine which, if any, biologic therapy is...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.